{"title":"Metabolic","description":"\u003ch1\u003ePeptides with metabolic effects\u003c\/h1\u003e\n\n\u003cp\u003e have been studied for their effects related to lipolysis, appetite control, energy balance, and regulation of metabolic pathways. Among them, Retatrutide has the strongest weight loss results in scientific studies.\u003c\/p\u003e","products":[{"product_id":"cjc-1295","title":"CJC-1295 (no DAC)\u003cbr\u003e 5mg","description":"\u003ch1\u003e\u003cstrong\u003eWhat is CJC-1295?\u003c\/strong\u003e\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eCJC-1295 (Mod GRF 1-29) is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH) composed of 29 amino acids. The modified version (Mod GRF 1-29) contains substitutions of several amino acids that make it more stable and biologically active compared to the original Sermorelin. Published data have shown that CJC-1295 stimulates the pituitary gland to secrete growth hormone (GH) by a natural physiological mechanism, enhancing physiological GH pulses. It is often combined with GHRP peptides (e.g. Ipamorelin) for a synergistic effect on GH secretion.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u0026nbsp;\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eObservations on CJC-1295\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eCJC-1295 (Mod GRF 1-29) is being studied for its possible effects on:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eGrowth hormone stimulation - observed activation of GH pulses and IGF-1 secretion.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eEffect on anabolism and protein synthesis.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eJoint and bone health - observed effect on mineralization and regeneration of bones and tendons.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eRegeneration and recovery - observed effect on recovery processes after exercise.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eSleep quality regulation - supports deep sleep phases.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eAnti-aging effects - observed effect on tissue regeneration and catabolic processes.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eMetabolic effect -\u003cmeta charset=\"UTF-8\"\u003e An effect on lipolysis has been observed in research models.\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003e\u003cstrong\u003eScientific data\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eCJC-1295 has been studied in clinical and preclinical settings.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn endocrinology, it shows effective increases in GH and IGF-1 with good tolerability.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIt is being studied in sports medicine for its role in recovery, muscle growth, and fat reduction.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn gerontology, interest is related to its potential to slow down aging processes by maintaining high levels of GH and IGF-1 in old age.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIts combination with GHRP peptides has been reported to be more effective than its use alone.\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eDosage and administration\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eThe scientific literature describes subcutaneous administration once daily at 100-300 μg daily, usually in the evening before bedtime.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eAt 5 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eConcentration = 1.67 mg\/ml → 0.06 ml = 100 μg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eExample values for 5 mg:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.06 ml = 100 μg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.12 ml = 200 μg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.18 ml = 300 μg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.24 ml = 400 μg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003e\u003cstrong\u003eApplication in sports\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eCJC-1295 is banned by WADA for use in professional sports because it can:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003estimulates the secretion of growth hormone\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eaccelerate muscle and tendon recovery\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eincrease muscle mass and strength\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003ehelp reduce fat\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003e\u003cstrong\u003ePossible side effects\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eReported side effects are rare and usually mild:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eredness or pain at the injection site\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003efatigue\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eheadache\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003emild fluid retention\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p1\"\u003eLess commonly, dizziness or temporary changes in appetite may occur.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cem\u003e\u003cspan class=\"s1\"\u003eThe information has been collected and systematized from various scientific sources and studies. It serves\u003c\/span\u003e educational purposes only \u003cspan class=\"s1\"\u003eand\u003c\/span\u003e should not be used for the diagnosis, treatment or prevention of diseases \u003cspan class=\"s1\"\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"5mg","offer_id":56337907515766,"sku":"PP-CJC1295-NODAC-5MG","price":45.0,"currency_code":"EUR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0941\/8965\/0294\/files\/cjc-1295-no-dacbr5mg-2052321.png?v=1760887999"},{"product_id":"hgh-frag-176-191","title":"hGH fragment 176-191\u003cbr\u003e 5mg","description":"\u003ch1\u003e\u003cstrong\u003eWhat is hGH Frag 176-191?\u003c\/strong\u003e\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003ehGH Fragment 176-191 is a synthetic peptide, a modified fragment (amino acids 176-191) of the C-terminal part of human growth hormone (hGH). It was created with the aim of isolating the lipolytic (fat-breaking) properties of GH without activating its other physiological effects. In the scientific literature, hGH Frag has been studied as a potential regulator of lipolysis and metabolic balance.\u003c\/p\u003e\n\u003c!-- Изображение --\u003e\n\u003cp class=\"p1\"\u003eUnlike full-length growth hormone, HGH Frag 176-191 does not show significant activity on IGF-1 levels and does not stimulate tissue growth. Instead, according to scientific studies, the peptide has been associated with stimulation of lipolysis and inhibition of lipogenesis, making it an interesting model for studying metabolic processes related to fat metabolism.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eHGH Frag Observations 176-191\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn the scientific literature, HGH Frag 176-191 has been studied in relation to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eStimulation of lipolysis - promotes the breakdown of fatty acids in adipocytes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eInhibition of lipogenesis - suppresses the accumulation of new fat cells\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eBody weight regulation - being studied as a potential metabolic modulator\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eMaintaining lean muscle mass - without anabolic effects typical of GH\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eVisceral fat reduction - in obesity models\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eImprovement in insulin sensitivity - observed in some preclinical studies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eScientific data\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eHGH Frag 176-191 has been studied in primarily preclinical models and limited clinical trials. Key scientific observations include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eIncreased lipolysis in adipocyte cultures and living models\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eReduction in total and visceral fat without change in IGF-1 levels\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eLack of effect on glucose homeostasis at low doses\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eNo effect on organ and tissue growth\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eImproved lipid metabolism and energy efficiency in some experimental models\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eDosage and administration\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn the scientific literature, doses quoted range from 250-500 μg daily, administered subcutaneously, often divided into 1-2 applications. The peptide is typically used in short-term research cycles (2-4 weeks) focused on lipolytic mechanisms.\u003c\/p\u003e\n\u003cp class=\"p4\"\u003eAt 5 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eConcentration = 1.67 mg\/ml → 0.06 ml = 100 μg\u003c\/p\u003e\n\u003cp class=\"p4\"\u003eExample values:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.06 ml = 100 μg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.12 ml = 200 μg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.18 ml = 300 μg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.24 ml = 400 μg\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eApplication in sports and research settings\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eHGH Fragment 176-191 is included in the WADA list of controlled substances and is not permitted for use by professional athletes. In a research context, the peptide is used to study lipolytic mechanisms and energy metabolism in various models of metabolic syndrome, obesity, and insulin resistance.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eModel for studying mechanisms of fat reduction\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eStudies on insulin sensitivity and lipid metabolism\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003ePossible synergy with other peptides regulating energy balance\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003ePossible side effects\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn research settings, HGH Frag 176-191 is considered well tolerated. The observed reactions are usually mild and transient:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eRedness or discomfort at the injection site\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eMild fatigue or drowsiness\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eHeadache at higher doses\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p1\"\u003eThere are no published data on serious side effects at research doses. The effects are dose-dependent and temporary.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cem\u003eThe information is based on scientific publications and is for educational purposes only. It is not intended to diagnose, treat or prevent disease.\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"5mg","offer_id":56381861658998,"sku":"PP-HGH-FRAG-5MG","price":35.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0941\/8965\/0294\/files\/hgh-frag-176-191br5mg-3748012.png?v=1760888001"},{"product_id":"b-bretatrutide-5mg-10mg","title":"Retatrutide 5mg\/10mg","description":"\u003ch1 class=\"p1\"\u003eWhat is Retatrutide?\u003c\/h1\u003e\n\u003cp\u003e\u003cspan\u003eRetatrutide is a synthetic peptide composed of 42 amino acids. It is characterized by a triple mechanism of action, as it simultaneously interacts with receptors for GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon. This combined receptor activity distinguishes it from other incretin analogs and is associated with a more complex effect on metabolic processes.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eInitially, the molecule was developed with a research focus on type 2 diabetes and obesity. Published clinical data describe a pronounced effect on reducing body weight, improving glycemic control, and favorably influencing some cardiovascular risk indicators.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eObservations on Retatrutide\u003c\/h2\u003e\n\u003cp\u003e\u003cspan\u003eIn scientific literature, retatrutide has been considered in relation to its potential influence on several key areas:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003e\u003cstrong\u003eGlucose metabolism control\u003c\/strong\u003e – reductions in HbA1c and indications of improved insulin sensitivity have been described in clinical and experimental settings.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003e\u003cstrong\u003eBody mass reduction\u003c\/strong\u003e – published results report a more pronounced reduction in adipose tissue compared to certain molecules with a dual mechanism.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003e\u003cstrong\u003eLiver indicators\u003c\/strong\u003e – studies have observed changes in lipid profiles and data indicating a significant reduction in hepatic steatosis, with some protocols reporting a reduction of approximately 80%.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003e\u003cstrong\u003eCardiometabolic markers\u003c\/strong\u003e – improvements in triglyceride levels, arterial pressure, and certain inflammatory indicators have been described.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003e\u003cstrong\u003eEnergy balance\u003c\/strong\u003e – scientific models have noted effects associated with increased energy expenditure, stimulated fat oxidation, and appetite suppression.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eScientific literature describes weekly subcutaneous administration. Studies begin with 2 mg and gradually titrate up to 4 mg weekly depending on tolerability and therapeutic effect.\u003c\/p\u003e\n\u003cp\u003eFor 5 mg + 2 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp\u003eConcentration = 2.5 mg\/ml → 0.4 ml = 1 mg\u003c\/p\u003e\n\u003cp\u003eExample values for 5 mg:\u003c\/p\u003e\n\u003cp\u003e0.1 ml = 0.25 mg\u003c\/p\u003e\n\u003cp\u003e0.2 ml = 0.5 mg\u003c\/p\u003e\n\u003cp\u003e0.3 ml = 0.75 mg\u003c\/p\u003e\n\u003cp\u003e0.4 ml = 1 mg\u003c\/p\u003e\n\u003cp\u003e0.5 ml = 1.25 mg\u003c\/p\u003e\n\u003cp\u003eFor 10 mg + 2 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp\u003eConcentration = 5 mg\/ml → 0.2 ml = 1 mg\u003c\/p\u003e\n\u003cp\u003eExample values for 10 mg:\u003c\/p\u003e\n\u003cp\u003e0.1 ml = 0.5 mg\u003c\/p\u003e\n\u003cp\u003e0.2 ml = 1 mg\u003c\/p\u003e\n\u003cp\u003e0.3 ml = 1.5 mg\u003c\/p\u003e\n\u003cp\u003e0.4 ml = 2 mg\u003c\/p\u003e\n\u003cp\u003e0.5 ml = 2.5 mg\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eScientific Data\u003c\/h2\u003e\n\u003cp\u003e\u003cspan\u003eRetatrutide has also been studied within the framework of the TRIUMPH-4 clinical trial, phase 3, lasting 68 weeks, conducted in adult participants with overweight or obesity and knee osteoarthritis, without the presence of diabetes. According to published topline results, the following effects were observed:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eAverage body weight reduction of up to 28.7% by week 68 in the 12 mg group\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eSignificant reduction in pain, measured by the WOMAC scale, with a reduction of up to approximately 75.8% from baseline, along with improvement in physical function\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eFavorable changes in individual cardiometabolic parameters, including non-HDL cholesterol, triglycerides, hsCRP, as well as a reduction in systolic arterial pressure at the highest dose studied\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003cbr\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eThe most commonly reported adverse reactions in scientific publications are \u003cspan class=\"s1\"\u003egastrointestinal\u003c\/span\u003e.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eThe literature indicates that manifestations are \u003cspan class=\"s1\"\u003edose-dependent\u003c\/span\u003e and may include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003enausea, vomiting, diarrhea or constipation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003ereduced appetite\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eabdominal discomfort\/bloating\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p1\"\u003eLess commonly, potentially more serious risks have been discussed, such as:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003epancreatitis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003egallstone disease, especially with faster weight reduction\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003ehypoglycemia when combined with other antidiabetic agents\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p1\"\u003e\u003cem\u003e\u003cspan class=\"s1\"\u003eThe information is collected and systematized from various scientific sources and studies. It is for educational purposes only and should not be used for diagnosis, treatment, or prevention of diseases.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e","brand":"PurePeptide","offers":[{"title":"5mg","offer_id":57637975884150,"sku":null,"price":59.0,"currency_code":"EUR","in_stock":true},{"title":"10mg","offer_id":57637975916918,"sku":null,"price":99.0,"currency_code":"EUR","in_stock":true},{"title":"30mg","offer_id":57677848904054,"sku":null,"price":250.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0941\/8965\/0294\/files\/retatrutide5mg_be6ce4b8-6fb7-4d80-911c-d155d6cab563.png?v=1775679159"},{"product_id":"aa-tirzepatide","title":"Tirzepatide 5mg\/10mg","description":"\u003ch1 class=\"p1\"\u003eWhat is Tirzepatide?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eTirzepatide is a synthetic peptide composed of 39 amino acids. It is a dual agonist of GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This combined activity distinguishes it from other incretin analogues that act only on the GLP-1 receptor.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eInitially developed for the treatment of type 2 diabetes mellitus, clinical trials have shown a pronounced effect on body weight reduction. In research models, improved insulin sensitivity, blood sugar control, and a positive impact on metabolic and cardiovascular parameters have been observed.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e \u003c\/p\u003e\n\u003ch2\u003eObservations on Tirzepatide\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eTirzepatide is being studied for its possible effects on:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eBlood sugar control – in research models, a decrease in HbA1c and glucose peaks has been observed.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eWeight reduction – an effect on body fat loss and improvement in body composition has been reported.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eMetabolic health – an improvement in lipid profile and reduction of hepatic steatosis has been observed.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eCardiovascular function – in research settings, a decrease in blood pressure and triglycerides has been reported.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eEnergy homeostasis – an effect related to increased fat oxidation and optimization of energy balance has been observed.\u003c\/p\u003e\n\u003cp class=\"p3\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eTirzepatide has been studied in large clinical trials, where it emerges as a potent incretin analogue with a wide range of benefits.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn patients with type 2 diabetes mellitus, the following have been reported:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- HbA1c reduction by up to 2%\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Weight loss of 10-15%\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Improvement in lipid profile and blood pressure\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn people with obesity without diabetes, the following have been observed:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Weight loss of up to 20% in 72 weeks\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Reduction of visceral fat\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Improvement in cardiometabolic parameters\u003c\/p\u003e\n\u003cp class=\"p3\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eSubcutaneous administration once a week has been described in scientific literature.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eStandard doses: 2.5 mg - initial dose with gradual titration up to 5 mg weekly depending on tolerance and therapeutic effect.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eFor 5 mg + 2 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp class=\"p2\"\u003eConcentration = 2.5 mg\/ml → 0.4 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003eExample values for 5 mg:\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.1 ml = 250μg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.2 ml = 500μg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.3 ml = 750μg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.4 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.5 ml = 1.25 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eFor 10 mg + 2 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp class=\"p2\"\u003eConcentration = 5 mg\/ml → 0.2 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003eExample values for 10 mg:\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.1 ml = 500μg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.2 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.3 ml = 1.5 mg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.4 ml = 2 mg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.5 ml = 2.5 mg\u003c\/p\u003e\n\u003cp class=\"p3\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eThe most commonly reported reactions are related to the gastrointestinal tract.\u003c\/p\u003e\n\u003cp class=\"p3\"\u003ePossible side effects are highly dose-dependent and include:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- nausea, vomiting, diarrhea, constipation\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- decreased appetite\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- abdominal discomfort\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eRarer but more serious risks include:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- pancreatitis\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- cholelithiasis with rapid weight reduction\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- hypoglycemia when combined with other antidiabetic agents\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cem\u003e\u003cspan class=\"s1\"\u003eThe information is gathered and systematized from various scientific sources and studies. It serves \u003c\/span\u003esolely for educational purposes\u003cspan class=\"s1\"\u003e and \u003c\/span\u003eshould not be used for diagnosis, treatment, or prevention of diseases\u003cspan class=\"s1\"\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e","brand":"PurePeptide","offers":[{"title":"5mg","offer_id":57637981389174,"sku":null,"price":59.0,"currency_code":"EUR","in_stock":true},{"title":"10mg","offer_id":57637981421942,"sku":null,"price":99.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0941\/8965\/0294\/files\/Tirzepatide5mg_8f0ac7ee-9d38-483a-ba85-2666858fe423.png?v=1775679820"},{"product_id":"a-a-semaglutide","title":"Semaglutide 5mg\/10mg","description":"\u003ch1 class=\"p1\"\u003eWhat is Semaglutide?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eSemaglutide is a synthetic peptide composed of 31 amino acids. It is a selective GLP-1 (glucagon-like peptide-1) receptor agonist, making it part of the incretin analogue group. The molecule has been modified to have an extended half-life, allowing for once-weekly administration.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eInitially, \u003cmeta charset=\"UTF-8\"\u003eit was developed and studied in the context of type 2 diabetes and obesity. \u003cmeta charset=\"UTF-8\"\u003eClinical trials observed an effect on weight reduction, blood sugar control, and improvement of cardio-metabolic parameters.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eObservations for Semaglutide\u003c\/h2\u003e\n\u003cp class=\"p3\"\u003eSemaglutide is being studied for its possible effects on:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cspan class=\"s1\"\u003eBlood sugar control\u003c\/span\u003e – a reduction in HbA1c and glucose peaks has been observed in research settings.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cspan class=\"s1\"\u003eWeight reduction\u003c\/span\u003e – an effect on body fat loss and improvement in body composition has been described.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cspan class=\"s1\"\u003eMetabolic health\u003c\/span\u003e – an effect on lipid profile and hepatic steatosis has been observed.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cspan class=\"s1\"\u003eCardiovascular function\u003c\/span\u003e – a reduction in blood pressure and atherogenic markers has been observed in research models.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cspan class=\"s1\"\u003eEnergy homeostasis\u003c\/span\u003e – an effect on appetite reduction and delayed gastric emptying has been described.\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eSemaglutide has been studied in numerous clinical trials.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn patients with type 2 diabetes, the following were reported:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Reduction in HbA1c by up to 1.8%\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Weight loss of 6-10%\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Improvement in lipid profile and blood pressure\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn people with obesity without diabetes, the following were observed:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Average weight loss of 12-15% over 68 weeks\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Reduction in visceral fat\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Improvement in cardio-metabolic parameters\u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003e\u003cbr\u003e\u003c\/h2\u003e\n\u003ch2 class=\"p1\"\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eSubcutaneous administration once weekly is described in the scientific literature.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eStandard doses: start with 0.25 mg weekly, then gradually titrate to 0.5 mg, 1 mg, and a maximum of 2.4 mg weekly.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eFor 2 mg + 2 ml bacteriostatic water: 1 mg\/ml → 1 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eFor 5 mg + 2 ml bacteriostatic water: 2.5 mg\/ml → 0.4 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eFor 10 mg + 2 ml bacteriostatic water: 5 mg\/ml → 0.2 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eExample values for 2 mg:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.25 ml = 0.25 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.5 ml = 0.5 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.75 ml = 0.75 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e1 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e1.25 ml = 1.25 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eExample values for 5 mg:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.1 ml = 0.25 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.2 ml = 0.5 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.3 ml = 0.75 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.4 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.5 ml = 1.25 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eExample values for 10 mg:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.1 ml = 0.5 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.2 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.3 ml = 1.5 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.4 ml = 2 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.5 ml = 2.5 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eThe most commonly reported reactions are related to the gastrointestinal tract.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003ePossible side effects are highly dose-dependent and include:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- nausea, vomiting, diarrhea, constipation\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- decreased appetite\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- abdominal discomfort\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eRarer but more serious risks include:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- pancreatitis\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- gallstone disease with rapid weight reduction\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- hypoglycemia when combined with other antidiabetic agents\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cem\u003e\u003cspan class=\"s1\"\u003eThe information is collected and systematized from various scientific sources and studies. It is for educational purposes only and should not be used for diagnosis, treatment, or prevention of diseases.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"PurePeptide","offers":[{"title":"5mg","offer_id":57638013469046,"sku":null,"price":49.0,"currency_code":"EUR","in_stock":true},{"title":"10mg","offer_id":57638013501814,"sku":null,"price":89.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0941\/8965\/0294\/files\/Semaglutide10mg_7af36663-439e-4a24-9222-1574277efc39.png?v=1775680538"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0941\/8965\/0294\/collections\/metabolizm-2324758.jpg?v=1760887941","url":"https:\/\/purepeptide-labs.com\/collections\/%d0%be%d1%82%d1%81%d0%bb%d0%b0%d0%b1%d0%b2%d0%b0%d0%bd%d0%b5.oembed","provider":"PurePeptide","version":"1.0","type":"link"}